FeesSafety
Pluang+

Ethereum whales buy millions in ETH amid price drop and heavy market selling

Technical Signals
09 Nov 2026, 15:33 WIB
Crypto news
View Source
Bullish
Ethereum whales buy millions in ETH amid price drop and heavy market selling

Large Ethereum holders, known as whales, have purchased millions of dollars worth of ETH despite recent price declines and heavy market selling. Notable transactions include a $21.55 million purchase funded by a $22 million USDT loan from Aave, and multiple wallets acquiring thousands of ETH at prices between $2,106 and $2,245. One wallet withdrew 34,601 ETH worth about $73.75 million from Binance after two years of inactivity. These activities contrast with significant outflows from US spot Ethereum ETFs, which saw $365.2 million in net withdrawals recently. This shows that while institutional products face selling pressure, some large investors are accumulating Ethereum during market weakness, possibly anticipating a rebound.

Ethereum whales and recent price moves provide context for Pluang's market snapshot. Of 50 major cryptocurrencies on Pluang, 17 rose and 32 fell today. Ethereum (ETH) traded at Rp38,383,333 with a 1-day change of -5.07% and Pluang order activity showing 36% Sell / 64% Buy as of Nov 09, 2026 20:02 WIB. Enjin Coin (ENJ) gained 4.40% with 100% buy activity, while XRP (Ripple) fell 5.09% with 62% buy activity.

More News

Microsoft to retire UWP Map Control by Nov 2026; OnTerra offers ready replacement using Azure Maps.

Microsoft to retire UWP Map Control by Nov 2026; OnTerra offers ready replacement using Azure Maps.

Microsoft will retire the backend services for its UWP Map Control and Windows Maps APIs on November 30, 2026, ending map functionality in many Windows desktop and tablet applications. OnTerra Systems, a Microsoft partner, has developed an off-the-sh...

Market News
Neutral
52 minutes ago
New combo therapy shows promise in tough metastatic breast cancer cases with high response rates

New combo therapy shows promise in tough metastatic breast cancer cases with high response rates

Marengo Therapeutics presented interim Phase 2 results from the STARt-002 trial combining invikafusp alfa, a selective T-cell agonist, with sacituzumab govitecan in metastatic triple-negative and HR-positive/HER2-negative breast cancer. The trial sho...

Company Fundamentals
Bullish
1 hour ago
Deadlines set for lead plaintiff appointments in class action lawsuits against Ensign, Netcapital, and Webull.

Deadlines set for lead plaintiff appointments in class action lawsuits against Ensign, Netcapital, and Webull.

Holzer & Holzer, LLC announced deadlines for investors to seek lead plaintiff status in shareholder class action lawsuits against The Ensign Group, Netcapital Inc., and Webull Corporation. These lawsuits allege misleading statements and failure to di...

Bearish
1 hour ago
Octave launches Attune Facilities, an AI-driven tool for managing complex multi-site operations efficiently.

Octave launches Attune Facilities, an AI-driven tool for managing complex multi-site operations efficiently.

Octave Intelligence plc has introduced Octave Attune Facilities, a cloud-based software solution designed to help organizations manage multiple sites with AI-powered tools. This platform integrates building, space, maintenance, and operational data t...

Market News
Bullish
1 hour ago
ITT Inc. price target raised to $259 after strong Q3 with 44% revenue growth and 20% earnings rise.

ITT Inc. price target raised to $259 after strong Q3 with 44% revenue growth and 20% earnings rise.

ITT Inc. reported a strong third quarter with revenue up 44% to over $1.40 billion and adjusted earnings rising 20% to $2.26 per share, driven by the SPX FLOW acquisition and 8% organic growth. Orders surged 58%, supported by aerospace, defense, and ...

Analyst Insights
Bullish
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App